I want to know more about treatment approaches / PRRT or Lutate

Suggested Resources

NeuroEndocrine Australia: PRRT Factsheet

Peptide Receptor Radionuclide Therapy (PRRT) is a targeted molecular therapy used to treat some NETs.

Watch this summary of PRRT Treatment and NETs

Click the button to watch the video

Prof Rod Hicks Director of Molecular Imaging and Co-Chair Neuroendocrine Service - Peter MacCallum Cancer Centre

Watch Prof Rod Hicks presentation PRRT for NETs Facts v Fiction

Dr David Pattison Deputy Director of Nuclear Medicine Royal Brisbane & Women's Hospital

Watch Dr Pattison present PRRT treatment at our Brisbane patient forum

Proudly supported by: